Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Stemtech Corp

Get SEC filing alerts via email and in your feed for Stemtech Corp

STEK

Stemtech Corp

About Stemtech Corp

Stemtech Corporation develops science-based stem cell enhancement products and dietary supplements aimed at supporting natural body renewal and anti-aging. Its core offerings include stem cell activation formulas, oral health products, skincare, and pet supplements. Operating globally through a network marketing model, the company leverages independent distributors to expand market reach, emphasizing natural, clinically supported ingredients and a direct-to-consumer approach.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from Stemtech Corp

1
1
Stemtech Corp Stemtech Corporation Reports 47% Decline in Net Sales for Q1 2026

Via official filing (AI summary) | 28 days ago | 0 comments

2
1
Stemtech Corp Stemtech Corporation Reports 43% Revenue Decline and Increased Net Loss for Fiscal Year 2025

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
Stemtech Corp Stemtech Corporation Reports Q3 2025 Financial Results with Reduced Net Loss and Declining Sales

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Stemtech Corp Stemtech Reports 47.4% Revenue Decline in Q2 2025, Despite Reduced Net Loss

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Stemtech Corp Stemtech Reports Decline in Net Sales and Increased Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Stemtech Corp Stemtech Corporation Reports 2.7% Increase in Net Sales, Faces $3.77 Million Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Stemtech Corp Stemtech Corporation Reports Mixed Q3 Results, Net Loss Increases Despite Cost-Cutting Measures

Via official filing (AI summary) | over 1 year ago | 0 comments